期刊文献+

1-乙酰基-3-邻甲基苯甲酰基-5-氟尿嘧啶含量及其杂质的高效液相色谱测定 被引量:2

Assay and Determination of Impurity for 1 - Acetyl -3-o -Toluyl- 5 - Fluorouracil and Its Preparation by HPLC
下载PDF
导出
摘要 目的:采用高效液相色谱法测定1-乙酰基-3-邻甲基苯甲酸基-5-氟尿嘧啶的含量及其有关物质。方法:以菲为内标物质,采用氰基柱(4.6mm×200mm,Nucleosil填料,粒度5μm),以5%冰醋酸乙腈溶液-0.5%醋酸铰溶液(60:40)为流动相,流速为1mL·min^(-1) ,紫外检测器在254nm处测定。结果:线性范围为0.2~1μg,r=0.999 9;平均回收率为99.9%;供试品溶液在2h内稳定;日内和日间测定的RSD分别为0.8%(n=6)和1.1%(n=5);杂质检出限为0.08ng。结论:采用高效液相色谱法测定1-乙酰基-3-邻甲基苯甲酰基-5-氟尿嘧啶的含量及其有关物质,方法简便准确,结果可靠。 Objective: A HPLC method for determination of 1 - acetyl - 3 - o - toluyl - 5 - fluorouracil (A - OT -Fu) and its impurity 3-o - toluyl -5 -fluorouracil (TFu) was developed. Method: International standard substance; phenantherene; Column; A 4. 6 mm × 200 mm stainless steel column filled with Nucleosil CN; Mo-bile phase; 5% glacial acetic acid in acetonitrile -0. 5% ammonium acetate in water (60:40) ; Flow rate; 1 mL · min-1 ; Detective wavelength; 254 nm. Results: The linear range of assay was 0. 2 - 1 μg (r =0. 999 9) ; The average recovery of A - OT - Fu was 99. 9% . The testing solution for assay was stable within 2 hours. The RSD of the determinations for single and repetitious were respectively 0. 8% (n =6) and 1.1% ( re = 5). The least detective limit of impurity was 0. 08 ng. Conclusion: The method established is rapid, accurate and relia-ble.
作者 党全训
出处 《药物分析杂志》 CAS CSCD 北大核心 2002年第3期234-236,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 1-乙酰基-3-邻甲基苯甲酰基-5-氟尿嘧啶 含量测定 邻甲基苯甲酰基氟尿嘧啶 高效液相色谱 抗肿瘤药 1- acetyl - 3 - o - toluyl - 5 - fluorouracil ( A - OT - Fu ) , assay ,3-o- toluyl - 5 - fluorouracil (TFu), HPLC
  • 相关文献

参考文献1

二级参考文献2

  • 1陈翊,中国医院药学杂志,1987年,7期,294页
  • 2赵冰,山东医科大学学报,1986年,24卷,43页

同被引文献17

  • 1黎远冬,梁宁生,李艳.HPLC法同时测定人体血浆中氟尿嘧啶及其前体药替加氟的浓度[J].药物分析杂志,2007,27(8):1205-1207. 被引量:7
  • 2Shore S,Raraty MG,Ghaneh P,et al.Review article:chemotherapy for pancreatic cancer.Aliment Pharmacol Ther,2003,18:1049.
  • 3Cohen EE,Lingen MW,Vokes EE.The expanding role of systemic therapy in head and neck cancer.J Clin Oncol,2004,22:1743.
  • 4Zufía L,Aldaz A,Castellanos C,et al.Determination of 5-fluorouracil and its prodrug tegafur in plasma and tissue by high-performance liquid chromatography in a single injection:validation for application in clinical pharmacokinetic studies.Ther Drug Monit,2003,25:221.
  • 5Carolina CC,Soledad C,Bartolome M,et al.Quantum dots luminescence enhancement due to illumination with UV/Vis light.Chem Commun,2009,35:5214.
  • 6Masilamany K,Ramaier N.L-cysteine-capped ZnS quantum dots based uorescence sensor for Cu2+ ion.Sens Actuators B Chem,2009,139:104.
  • 7Chansik P,Tae HY.L-cysteine-induced photoluminescence enhancement of CdSe/ZnSe quantum dots in aqueous solution.Colloids Surf B Biointerfaces,2010,75:472.
  • 8Wang LL,Zheng HZ,Long YJ.Rapid determination of the toxicity of quantum dots with luminous bacteria.J Hazard Mater,2010,177:1134.
  • 9He Y,Wang HF,Yan XP.Exploring Mn-doped ZnS quantum dots for the room-temperature phosphorescence detection of enoxacin in biological fluids.Anal Chem,2008,80(10):3832.
  • 10Wang XF,Xu JJ,Chen HY.A new electrochemiluminescence emission of Mn2+-doped ZnS nanocrystals in aqueous solution.J Phys Chem C,2008,112:17581.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部